
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
Think you've been around a long time? When's the last time your company gave a doctor a cigarette lighter with your logo on it? Put any corks in medicine bottles lately? Can you remember the last hero shot of a pharma CEO on the cover of Time? We can. And we have the artifacts to prove it...
over 20 years ago
Getting Betterover 20 years ago
States Curb Marketingover 20 years ago
From the Editor: Take Your Seatover 20 years ago
Viewpoint: In Your Wordsover 20 years ago
Quiz Answersover 20 years ago
Introduction: Pharm Exec at 25over 20 years ago
How Far We've Come





